278 related articles for article (PubMed ID: 29751876)
1. Recent Advances in the Histopathology of Drug-Induced Liver Injury.
Kleiner DE
Surg Pathol Clin; 2018 Jun; 11(2):297-311. PubMed ID: 29751876
[TBL] [Abstract][Full Text] [Related]
2. Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center.
Ettel M; Gonzalez GA; Gera S; Eze O; Sigal S; Park JS; Xu R
Hum Pathol; 2017 Oct; 68():92-98. PubMed ID: 28873351
[TBL] [Abstract][Full Text] [Related]
3. "Autoimmune(-Like)" Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis.
Sebode M; Schulz L; Lohse AW
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28895915
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis: Liver biopsy differentiates DILI from autoimmune hepatitis.
Lewis JH
Nat Rev Gastroenterol Hepatol; 2011 Aug; 8(10):540-2. PubMed ID: 21862981
[No Abstract] [Full Text] [Related]
5. Severe cholestatic hepatitis due to temozolomide: an adverse drug effect to keep in mind. Case report and review of literature.
Grieco A; Tafuri MA; Biolato M; Diletto B; Di Napoli N; Balducci N; Vecchio FM; Miele L
Medicine (Baltimore); 2015 Mar; 94(12):e476. PubMed ID: 25816026
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced Liver Injury: The Hepatic Pathologist's Approach.
Kleiner DE
Gastroenterol Clin North Am; 2017 Jun; 46(2):273-296. PubMed ID: 28506365
[TBL] [Abstract][Full Text] [Related]
7. Clinical and histological features of idiosyncratic acute liver injury caused by temozolomide.
Grant LM; Kleiner DE; Conjeevaram HS; Vuppalanchi R; Lee WM
Dig Dis Sci; 2013 May; 58(5):1415-21. PubMed ID: 23212393
[TBL] [Abstract][Full Text] [Related]
8. Temozolomide: fatal hepatic failure.
Prescrire Int; 2014 Sep; 23(152):214. PubMed ID: 25325123
[No Abstract] [Full Text] [Related]
9. Temozolomide induced liver injury.
Dixit S; Hingorani M; Afzal P; Campbell AP
Acta Neurol Belg; 2011 Sep; 111(3):249-51. PubMed ID: 22141295
[TBL] [Abstract][Full Text] [Related]
10. Temozolomide-induced liver damage. A case report.
Becker F; Hecht M; Schmidtner J; Semrau S; Fietkau R
Strahlenther Onkol; 2014 Apr; 190(4):408-10. PubMed ID: 24452817
[TBL] [Abstract][Full Text] [Related]
11. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury.
Suzuki A; Brunt EM; Kleiner DE; Miquel R; Smyrk TC; Andrade RJ; Lucena MI; Castiella A; Lindor K; Björnsson E
Hepatology; 2011 Sep; 54(3):931-9. PubMed ID: 21674554
[TBL] [Abstract][Full Text] [Related]
12. Something old, something new: liver injury associated with total parenteral nutrition therapy and immune checkpoint inhibitors.
Meyerson C; Naini BV
Hum Pathol; 2020 Feb; 96():39-47. PubMed ID: 31669893
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced cholestatic hepatitis: how late can it occur even after the cessation of the culpable drug?
Zamani N; Mohammad Alizadeh A
Neuro Oncol; 2012 Jul; 14(7):830. PubMed ID: 22544734
[No Abstract] [Full Text] [Related]
14. Valproic acid related idiosyncratic drug induced hepatotoxicity in a glioblastoma patient treated with temozolomide.
Neyns B; Hoorens A; Stupp R
Acta Neurol Belg; 2008 Dec; 108(4):131-4. PubMed ID: 19239041
[TBL] [Abstract][Full Text] [Related]
15. [Clinical features of drug-induced autoimmune hepatitis and drug-induced liver injury: a comparative analysis].
Zhao SX; Zhang YG; Tan PF; Wang RQ; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):302-6. PubMed ID: 27470631
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced liver injury with autoimmune features complicated with hemophagocytic syndrome.
Hayashi M; Abe K; Imaizumi H; Okai K; Kanno Y; Takahashi A; Ohira H
Clin J Gastroenterol; 2016 Jun; 9(3):150-5. PubMed ID: 27076346
[TBL] [Abstract][Full Text] [Related]
17. The pathology of drug-induced liver injury.
Kleiner DE
Semin Liver Dis; 2009 Nov; 29(4):364-72. PubMed ID: 19826970
[TBL] [Abstract][Full Text] [Related]
18. Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system.
Sarganas G; Orzechowski HD; Klimpel A; Thomae M; Kauffmann W; Herbst H; Bronder E; Garbe E
Neuro Oncol; 2012 May; 14(5):541-6. PubMed ID: 22394496
[TBL] [Abstract][Full Text] [Related]
19. Acute temozolomide induced liver injury : Mixed type hepatocellular and cholestatic toxicity.
Aygun C; Altınok AY; Çakır A; Agan AF; Balaban Y
Acta Gastroenterol Belg; 2016; 79(4):487-489. PubMed ID: 28209108
[TBL] [Abstract][Full Text] [Related]
20. Liver injury from herbal and dietary supplements.
Navarro VJ; Khan I; Björnsson E; Seeff LB; Serrano J; Hoofnagle JH
Hepatology; 2017 Jan; 65(1):363-373. PubMed ID: 27677775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
